Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00502
|
|||||
Drug Name |
Chlorpromazine
|
|||||
Synonyms |
10-(3-Dimethylaminopropyl)-2-chlorophenothiazine; 10H-Phenothiazine-10-propanamine, 2-chloro-N,N-dimethyl-, radical ion(1+); 2-Chloro-10-(3-(dimethylamino)propyl)phenothiazine; 2-Chloro-10-[3-(dimethylamino)propyl]phenothiazine; 2-Chloropromazine; 2-Cloro-10 (3-dimetilaminopropil)fenotiazina; 2-Cloro-10 (3-dimetilaminopropil)fenotiazina [Italian]; 2-chloro-10-(3-(dimethylamino)propyl)-phenothiazine; 2-chloro-N,N-dimethyl-10H-Phenothiazine-10-propanamine; 3-(2-Chloro-10H-phenothiazin-10-yl)-N,N-dimethyl-1-propanamine; 3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine; 3-(2-chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine; 3-(2-chlorophenothiazin-10-yl)-N,N-dimethylpropan-1-amine; Aminasine; Aminazin; Aminazine; Ampliactil; Amplicitil; Amplictil; BC 135; Chlor-PZ; Chlor-Promanyl; Chlordelazine; Chlorderazin; Chloro-3 (dimethylamino-3 propyl)-10 phenothiazine; Chloro-3 (dimethylamino-3 propyl)-10 phenothiazine [French]; Chloropromazine; Chlorpromados; Chlorpromanyl (discontinued); Chlorpromazin; Chlorpromazine (USP/INN); Chlorpromazine Tannate; Chlorpromazine [USAN:INN:BAN]; Chlorpromazinum; Chlorpromazinum [INN-Latin]; Clorpromazina; Clorpromazina [INN-Spanish]; Clorpromazina [Italian]; Contomin; Cromedazine; Elmarin; Esmind; Fenactil; Fenaktyl; Fraction AB; HL 5746; JHICC02042; Largactil; Largactil (TN); Largactil Liquid; Largactil Oral Drops; Largactilothiazine; Largactyl; Megaphen; N-(3-Dimethylaminopropyl)-3-chlorophenothiazine; Novo-Chlorpromazine; Novomazina; Phenactyl; Phenathyl; Phenothiazine hydrochloride; Plegomasine; Plegomazin; Prazilpromactil; Proma; Promactil; Promazil; Propaphen; Propaphenin; Prozil; Psychozine; SKF 2601-A; SKF 2601A; SKF-2601; Sanopron; Thorazine; Thorazine (TN); Thorazine Spansule; Thorazine Suppositories; Thorazine hydrochloride; Torazina; Wintermin; Z80; [3-(2-Chloro-phenothiazin-10-yl)-propyl]-dimethyl-amine
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Schizophrenia [ICD11: 6A20] | Approved | [1] | |||
Therapeutic Class |
Antipsychotic Agents
|
|||||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C17H19ClN2S
|
|||||
Canonical SMILES |
CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl
|
|||||
InChI |
InChI=1S/C17H19ClN2S/c1-19(2)10-5-11-20-14-6-3-4-7-16(14)21-17-9-8-13(18)12-15(17)20/h3-4,6-9,12H,5,10-11H2,1-2H3
|
|||||
InChIKey |
ZPEIMTDSQAKGNT-UHFFFAOYSA-N
|
|||||
CAS Number |
CAS 50-53-3
|
|||||
Pharmaceutical Properties | Molecular Weight | 318.9 | Topological Polar Surface Area | 31.8 | ||
Heavy Atom Count | 21 | Rotatable Bond Count | 4 | |||
Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 3 | |||
XLogP |
5.2
|
|||||
PubChem CID | ||||||
PubChem SID |
10524433
, 10588932
, 11110990
, 11110991
, 11120337
, 11120825
, 11121313
, 11335799
, 11361038
, 11363036
, 11364725
, 11365598
, 11367287
, 11368160
, 11369849
, 11371331
, 11372890
, 11373945
, 11375449
, 11376322
, 11378013
, 11462010
, 11466092
, 11467212
, 11484847
, 11485904
, 11488972
, 11490162
, 11492098
, 11493956
, 12014508
, 14923746
, 24398080
, 25688547
, 26611657
, 26680205
, 26747094
, 26747095
, 26751620
, 26751621
, 29221882
, 4332427
, 441206
, 602724
, 7847336
, 7978926
, 8149253
, 8151764
, 841999
, 9123
|
|||||
ChEBI ID |
ChEBI:3647
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
Drug-Transporter Activity Data | ||||||
Drug-Transporter Activity Data | P-GP | Transporter Info | Km = 27.4 microM | Baculovirus-infected insect cells-MDR1 | [3] | |
References | ||||||
1 | Chlorpromazine was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
2 | Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade. Cancer Lett. 2016 Jan 1;370(1):153-64. | |||||
3 | In vitro P-glycoprotein affinity for atypical and conventional antipsychotics. Life Sci. 2002 May 31;71(2):163-9. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.